SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-24-000041
Filing Date
2024-01-02
Accepted
2024-01-02 16:16:46
Documents
2
Period of Report
2024-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 13547
2 EX-24 DOCUMENT attachment1.htm EX-24 4319
  Complete submission text file 0000899243-24-000041.txt   19340
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Issuer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MEREO BIOPHARMA 1 CAVENDISH PLACE LONDON X0 W1G 0QF
Business Address
Hughes-Wilson Alexandra (Reporting) CIK: 0002005875 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38452 | Film No.: 24502614